Nuvation Bio Inc. SEC filings NUVB
Nuvation Bio Inc. has 400 filings in SEC EDGAR's recent list, going back to May 15, 2020. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
New debt, Other events
|
Jul 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Other events
|
Jun 30, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 27, 2026 | May 21, 2026 |
| 8-K |
Current report
Results of operations
|
May 4, 2026 | May 4, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 26, 2025 | Nov 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 17, 2025 | Nov 17, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 11, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2025 | May 21, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 25, 2025 | Mar 21, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 5, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 4, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 12, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 7, 2024 | Oct 7, 2024 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Sep 5, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2024 | Aug 5, 2024 |
| 8-K/A |
Amended current report
Other events
|
Jun 20, 2024 | Apr 9, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
|
Apr 10, 2024 | Apr 9, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Mar 25, 2024 | Mar 24, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 14, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 27, 2023 | Nov 27, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 13, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 16, 2023 | May 16, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Other events
|
Mar 2, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 23, 2022 | Dec 23, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Other events
|
Aug 1, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 17, 2022 | May 16, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Results of operations
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Agreement ended
|
Oct 28, 2021 | Oct 22, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 4, 2021 | Jun 1, 2021 |
| 8-K |
Current report
Results of operations
|
May 17, 2021 | May 17, 2021 |
| 8-K |
Current report
Restatement
|
May 14, 2021 | May 14, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 11, 2021 | Mar 9, 2021 |
| 8-K/A | Amended current report | Mar 11, 2021 | Feb 10, 2021 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Listing notice, Change to shareholder rights, Auditor change, Officer or director change, Bylaw or fiscal year change
|
Feb 12, 2021 | Feb 10, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Feb 9, 2021 | Feb 9, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 21, 2020 | Oct 20, 2020 |
| 8-K |
Current report
Other events
|
Aug 20, 2020 | Aug 20, 2020 |
| 8-K |
Current report
Other events
|
Jul 10, 2020 | Jul 6, 2020 |
| 8-K |
Current report
Other events
|
Jul 6, 2020 | Jul 6, 2020 |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NUVB (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1811063
- Former names
- Panacea Acquisition Corp (until Feb 11, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.